Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 12:15 save search
Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
EDSA | $4.3 -3.7% -3.84% 5.1K
|
Health Technology
|
| O: 68.6%
H: 26.98%
C: 26.14%
covid phase 2 positive antibody biotech iot covid-19
Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option
Published: 2021-08-20 (Crawled : 12:15) - feed.businesswire.com
RGC | $5.7 -10.84% 2.6K
|
Manufacturing
|
| O: 67.78%
H: 0.0%
C: 0.0%
bioscience
HCW Biologics Receives FDA Clearance to Proceed with Phase 1b Clinical Trial for Immunotherapeutic HCW9218 for Pancreatic Cancer
Published: 2021-10-28 (Crawled : 12:15) - biospace.com/
HCWB | $1.6036 -1.24% 890
|
|
| O: 60.62%
H: 50.32%
C: 0.85%
fda clearance fda phase 1 cancer phase 1b trial pancreatic hcw9218 pancreas phase 2b clearance
Exela Technologies adds Robotic Process Automation (RPA) platform for a large health insurance company
Published: 2021-06-29 (Crawled : 12:15) - globenewswire.com
XELA | $1.92 -1.54% -1.56% 130K
|
Technology Services
|
| O: 51.02%
H: 16.22%
C: 5.41%
insurance health
Galectin Therapeutics Announces Positive Top-Line Results from a Phase 1b Clinical Trial Extension of Belapectin in Combination with KEYTRUDA® in Advanced Metastatic Melanoma and Head and Neck Cancer
Published: 2021-07-09 (Crawled : 12:15) - globenewswire.com
GALT | $3.29 -2.66% -2.74% 160K
|
Health Technology
|
| O: 43.48%
H: 11.11%
C: -12.88%
phase 1 positive results cancer trial topline galectin-3 phase 1b keytruda phase 2b
Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody ProgramAgenus to receive a $200 million upfront payment and up to $1.36 billion in milestone payments
Published: 2021-05-18 (Crawled : 12:15) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.06%
H: 0.58%
C: 0.28%
AGEN A | $7.42 14.86% 12.94% 1.3M
|
Health Technology
|
| O: 29.45%
H: 6.64%
C: -6.87%
antibody license milestone
TAOP Signs Strategic Cooperation Agreement with Shenzhen IntelStrat Technology Co., Ltd
Published: 2021-07-30 (Crawled : 12:15) - globenewswire.com
TAOP | $1.06 -1.85% -1.89% 99K
|
Technology Services
|
| O: 26.09%
H: 0.0%
C: 0.0%
technology
TAOP Signs Agreement to Acquire Majority Stake in Render Lake Tech Ltd. and Launches NFT Division
Published: 2021-03-31 (Crawled : 12:15) - globenewswire.com
TAOP | $1.06 -1.85% -1.89% 99K
|
Technology Services
|
| O: 25.25%
H: 4.76%
C: -25.32%
Allena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ALLN-346 for Chronic Treatment of Hyperuricemia in Patients With Gout and Advanced Chronic Kidney Disease
Published: 2021-11-03 (Crawled : 12:15) - globenewswire.com
ALNA | $0.075 -12.0%
|
Health Technology
|
| O: 22.35%
H: 12.5%
C: -3.85%
disease treatment fda fast track fast track designation kidney designation
CPS Technologies Corporation Receives Additional HybridTech Armor® Panels Order For U.S. Aircraft Carriers
Published: 2021-05-20 (Crawled : 12:15) - globenewswire.com
CPSH | $1.77 -0.55% 1.6K
|
Producer Manufacturing
|
| O: 21.78%
H: 2.89%
C: -8.94%
order
INBRX-101 Shows Favorable Safety Profile in Patients with Alpha-1 Antitrypsin Deficiency and Demonstrates the Potential to Achieve Normal Alpha-1 Antitrypsin Levels with Monthly Dosing
Published: 2021-10-12 (Crawled : 12:15) - biospace.com/
INBX | $34.385 0.75% 0.74% 220K
|
Health Technology
|
| O: 20.79%
H: 9.66%
C: 0.99%
potential
Dunxin Financial Holding Limited (NYSE MKT: DXF) Announces Transformation of Business into Metaverse and Block Chain Industry
Published: 2021-11-10 (Crawled : 12:15) - prnewswire.com
DXF | $0.262 7.78% -6.45% 120K
|
Finance
|
| O: 19.87%
H: 6.18%
C: -4.49%
metaverse
WiMi HoloPluse LiDAR Approved by the Federal Communications Commission to Enter the U.S. Market
Published: 2021-11-02 (Crawled : 12:15) - prnewswire.com
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
|
| O: 19.09%
H: 0.7%
C: -6.62%
communication communications lidar
APYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR THE USE OF RENUVION TO IMPROVE APPEARANCE OF LAX (LOOSE) SKIN
Published: 2022-07-18 (Crawled : 12:15) - apyxmedical.com
APYX | $1.495 13.26% 11.71% 190K
|
Health Technology
|
| O: 18.16%
H: 0.0%
C: 0.0%
fda clearance renuvion skin corporation
Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update
Published: 2021-11-03 (Crawled : 12:15) - ir.check-cap.com
CHEK | $2.29 -0.89% 25K
|
Health Technology
|
| O: 17.78%
H: 0.88%
C: -8.04%
financial results results
UNITY Biotechnology Reports Granting of New Employment Inducement Awards
Published: 2021-11-03 (Crawled : 12:15) - globenewswire.com
UBX | $1.48 -0.67% -0.68% 82K
|
Health Technology
|
| O: 17.49%
H: 0.09%
C: -12.6%
biotech technology iot granted grant awards
Nexters Inc to Announce Second Quarter 2021 Financial Results on September 22, 2021
Published: 2021-09-17 (Crawled : 12:15) - globenewswire.com
GDEV | $2.235 -0.27% 22K
|
|
| O: 17.41%
H: 0.0%
C: 0.0%
financial results results
Magnachip Confirms Receipt of Unsolicited Proposal
Published: 2021-06-11 (Crawled : 12:15) - prnewswire.com
MX | $4.83 -0.82% 0.0% 200K
|
Electronic Technology
|
| O: 16.44%
H: 0.22%
C: -3.46%
chip
Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer
Published: 2021-05-27 (Crawled : 12:15) - biospace.com/
LNTH | $65.19 1.21% 1.2% 580K
|
Health Technology
|
| O: 16.15%
H: 6.78%
C: 0.53%
fda prostate cancer fda approval injection cancer imaging approval pylarify commercialization
Finch Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
FNCH | $2.305 -17.35% -20.99% 120K
|
Professional, Scientific, and T...
|
| O: 15.94%
H: 0.19%
C: -7.44%
financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.